The Latest Cardiac and Vascular News
PASADENA, Calif.–(BUSINESS WIRE)–Arrowhead Pharmaceuticals Inc. (NASDAQ: ARWR) today announced that it has dosed the first patient in AROANG3-2001, a Phase 2b clinical study of ARO-ANG3, the company’s investigational RNA interference (RNAi) therapeutic being developed as a treatment for patients with mixed dyslipidemia. Javier San Martin, M.D., chief medical officer at […]
CARLSBAD, Calif.–(BUSINESS WIRE)–Ra Medical Systems, Inc. (NYSE American: RMED), a medical device company focused on commercializing excimer laser systems to treat vascular and dermatological diseases, announces progress with finalizing the next-generation guidewire-compatible DABRA catheter design following a recent two-day, hands-on workshop with interventionalists who evaluated prototypes of the next-generation excimer […]
MARLBOROUGH, Mass., June 29, 2021 /PRNewswire/ — CardioFocus, Inc., a medical device company dedicated to advancing ablation treatment for atrial fibrillation (AFib), today announced the appointment of Stephan Ogilvie as its Chief Financial Officer. Mr. Ogilvie’s career spans decades in the medical technology sector and includes leadership roles in sales and marketing and corporate development, […]
SOUTH SAN FRANCISCO, Calif.–(BUSINESS WIRE)–Presidio Medical, Inc., a clinical-stage medical device company developing a transformational neuromodulation platform, today announced that Michael Onuscheck has been named the incoming Chief Executive Officer and Chairman of the Board. Mr. Onuscheck will be stepping down from his roles at Alcon, where he served as […]
DANVERS, Mass.–(BUSINESS WIRE)–Abiomed’s (NASDAQ: ABMD) newest right heart pump, the Impella RP with SmartAssist, has received U.S. Food and Drug Administration (FDA) pre-market approval (PMA) as safe and effective to treat acute right heart failure for up to 14 days. Impella RP with SmartAssist is the first single-access temporary percutaneous ventricular […]
DEFINE AFib Study Will Leverage Data from Medtronic Insertable Cardiac Monitors and Medtronic Discovery App™ with the Goal of Informing Atrial Fibrillation (AF) Management Strategies DUBLIN, June 29, 2021 /PRNewswire/ — Medtronic plc (NYSE:MDT), the global leader in medical technology, today announced the initiation of the DEFINE AFib study, the company’s first […]
After three years of research and development, Front Line Medical Technologies introduces the world’s smallest REBOA device to control bleeding and help patients survive emergencies LONDON, Ontario, June 29, 2021 (GLOBE NEWSWIRE) — Front Line Medical Technologies, Inc. announced today that the U.S. Food and Drug Administration (FDA) has cleared its COBRA-OS™ […]
Large-scale phase 3 trial shows significant reduction in cardiovascular and kidney disease risk First public reveal of results from large-scale, Sanofi-led global phase 3 trial for efpeglenatide Hanmi aims to achieve new innovations with biologic SEOUL, South Korea, June 29, 2021 /PRNewswire/ — Hanmi Pharmaceutical (hereinafter Hanmi) recently announced that its new, […]
DENVER, June 29, 2021 /PRNewswire/ — Dr. Charles Nutting, DO FSIR and ECCO Medical, the leading endovascular treatment center in Colorado, are pleased to announce their participation in the Embrace™ Hydrogel Embolic System (HES) global randomized clinical trial for the treatment of hypervascular tumors. The study is sponsored by Instylla, Inc. and focuses on […]
Appointments to be effective upon closing of the previously announced merger between Renovacor and Chardan Healthcare Acquisition 2 Corp. PHILADELPHIA, June 29, 2021 (GLOBE NEWSWIRE) — Renovacor, Inc. (“Renovacor”), an early‑stage biotechnology company developing adeno-associated virus (AAV)‑based gene therapies for devastating cardiovascular and central nervous system diseases resulting from BAG3 gene variants, […]
